Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Erythromycin stearate - Generic Drug Details

« Back to Dashboard
Erythromycin stearate is the generic ingredient in eight branded drugs marketed by Bristol, Mylan, Bristol Myers Squibb, Watson Labs, Warner Chilcott, Parke Davis, Purepac Pharm, Arbor Pharms Llc, Ani Pharms Inc, Wyeth Ayerst, Lederle, and Pfizer, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.

There are ninety-seven drug master file entries for erythromycin stearate. Seven suppliers are listed for this compound.

Summary for Generic Name: erythromycin stearate

Drug Master File Entries: see list97
Suppliers / Packaging: see list7
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details

Pharmacology for Ingredient: erythromycin stearate

Clinical Trials for: erythromycin stearate

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs
erythromycin stearate
TABLET;ORAL062121-001Approved Prior to Jan 1, 1982DISCNNo<disabled><disabled>
Arbor Pharms Llc
erythromycin stearate
TABLET;ORAL060359-002Approved Prior to Jan 1, 1982DISCNNo<disabled><disabled>
erythromycin stearate
TABLET;ORAL062089-001Approved Prior to Jan 1, 1982DISCNNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?